Mammoth Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Mammoth Biosciences's estimated annual revenue is currently $34.6M per year.
- Mammoth Biosciences's estimated revenue per employee is $155,000
- Mammoth Biosciences's total funding is $264.5M.
- Mammoth Biosciences's current valuation is $1B.
Employee Data
- Mammoth Biosciences has 223 Employees.
- Mammoth Biosciences grew their employee count by -4% last year.
Mammoth Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder & CTO | Reveal Email/Phone |
2 | Co-Founder and CEO | Reveal Email/Phone |
3 | Cofounder & CSO | Reveal Email/Phone |
4 | COO & CFO | Reveal Email/Phone |
5 | COO and CFO | Reveal Email/Phone |
6 | VP, Corporate Controller | Reveal Email/Phone |
7 | VP Product Development | Reveal Email/Phone |
8 | General Counsel | Reveal Email/Phone |
9 | SVP, Finance | Reveal Email/Phone |
10 | General Counsel | Reveal Email/Phone |
Mammoth Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Mammoth Biosciences?
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13 and Cas14, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.
keywords:N/A
$264.5M
Total Funding
223
Number of Employees
$34.6M
Revenue (est)
-4%
Employee Growth %
$1B
Valuation
N/A
Accelerator
Mammoth Biosciences News
Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering...
Gene editing company Mammoth Biosciences this week announced multiple executive appointments. Elaine Sun has been named chief operating...
Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, has appointed Elaine Sun...
Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced it has secured $195 million in financing, joining the select ranks of “unicorn” startups with a valuation of more than $1 billion. ...
California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to deliver accurate, fast results using a handheld, disposable testing platform. Mammoth Biosciences will be using its DETECTR platform to develop the test, ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $43.8M | 226 | 16% | $239.1M |
#2 | $34.2M | 227 | -22% | $35M |
#3 | $55.7M | 230 | 8% | N/A |
#4 | $37.7M | 243 | -7% | N/A |
#5 | $48.6M | 251 | -4% | $65M |